Summary
Updated Aug 30, 2026
Andrew Dreyfus is Director of Alto Neuroscience, Inc. (ANRO). 1 SEC Form 4 filing on record, dated 14 May 2026.
Trading Pattern
InsiderAlpha's records for Andrew Dreyfus go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Andrew Dreyfus's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- GENERAL ATLANTIC, L.P. - $315.49M of ALHC open-market activity in the last 12 months
- Fairmount Funds Management LLC - $300.01M of ORKA open-market activity in the last 12 months
- August J. Troendle - $249.99M of MEDP open-market activity in the last 12 months
- A/S Genmab - $234.86M of MRUS open-market activity in the last 12 months
- Weiss Asset Management LP - $233.35M of AVDL open-market activity in the last 12 months
- James Edgemond - $201.52M of UTHR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Andrew Dreyfus?
Andrew Dreyfus is a corporate insider, tracked as Director of Alto Neuroscience, Inc. (ANRO). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Andrew Dreyfus last file a Form 4?
The only primary Form 4 on record is dated 14 May 2026.
Where can I see all of Andrew Dreyfus's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Andrew Dreyfus and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial